These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2363 related articles for article (PubMed ID: 32241274)

  • 1. SCNrank: spectral clustering for network-based ranking to reveal potential drug targets and its application in pancreatic ductal adenocarcinoma.
    Liu E; Zhang ZZ; Cheng X; Liu X; Cheng L
    BMC Med Genomics; 2020 Apr; 13(Suppl 5):50. PubMed ID: 32241274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of hub genes and regulators associated with pancreatic ductal adenocarcinoma based on integrated gene expression profile analysis.
    Shang M; Zhang L; Chen X; Zheng S
    Discov Med; 2019 Sep; 28(153):159-172. PubMed ID: 31926587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pooled CRISPR screening in pancreatic cancer cells implicates co-repressor complexes as a cause of multiple drug resistance via regulation of epithelial-to-mesenchymal transition.
    Ramaker RC; Hardigan AA; Gordon ER; Wright CA; Myers RM; Cooper SJ
    BMC Cancer; 2021 May; 21(1):632. PubMed ID: 34049503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of novel genes associated with a poor prognosis in pancreatic ductal adenocarcinoma via a bioinformatics analysis.
    Zhou J; Hui X; Mao Y; Fan L
    Biosci Rep; 2019 Aug; 39(8):. PubMed ID: 31311829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Network-Based Approach for Identification of Subtype-Specific Master Regulators in Pancreatic Ductal Adenocarcinoma.
    Zhang Y; Zhu L; Wang X
    Genes (Basel); 2020 Feb; 11(2):. PubMed ID: 32024063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deciphering the Prognostic Implications of the Components and Signatures in the Immune Microenvironment of Pancreatic Ductal Adenocarcinoma.
    Tang R; Liu X; Liang C; Hua J; Xu J; Wang W; Meng Q; Liu J; Zhang B; Yu X; Shi S
    Front Immunol; 2021; 12():648917. PubMed ID: 33777046
    [No Abstract]   [Full Text] [Related]  

  • 7. Identification of differentially expressed genes in pancreatic ductal adenocarcinoma and normal pancreatic tissues based on microarray datasets.
    Liu L; Wang S; Cen C; Peng S; Chen Y; Li X; Diao N; Li Q; Ma L; Han P
    Mol Med Rep; 2019 Aug; 20(2):1901-1914. PubMed ID: 31257501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene signature and connectivity mapping to assist with drug prediction for pancreatic ductal adenocarcinoma.
    Xiao Y; Zhang B; Cloyd JM; Xu G; Du S; Mao Y; Pawlik TM
    Surg Oncol; 2022 Sep; 44():101849. PubMed ID: 36116415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of candidate miRNA biomarkers for pancreatic ductal adenocarcinoma by weighted gene co-expression network analysis.
    Giulietti M; Occhipinti G; Principato G; Piva F
    Cell Oncol (Dordr); 2017 Apr; 40(2):181-192. PubMed ID: 28205147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Weighted gene co-expression network analysis reveals key genes involved in pancreatic ductal adenocarcinoma development.
    Giulietti M; Occhipinti G; Principato G; Piva F
    Cell Oncol (Dordr); 2016 Aug; 39(4):379-88. PubMed ID: 27240826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systematic Analysis of Alternative Splicing Landscape in Pancreatic Adenocarcinoma Reveals Regulatory Network Associated with Tumorigenesis and Immune Response.
    Lu J; Wei S; Lou J; Yin S; Zhou L; Zhang W; Zheng S
    Med Sci Monit; 2020 Jul; 26():e925733. PubMed ID: 32706768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene expression profiling of 1200 pancreatic ductal adenocarcinoma reveals novel subtypes.
    Zhao L; Zhao H; Yan H
    BMC Cancer; 2018 May; 18(1):603. PubMed ID: 29843660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and validation of glycolysis-related prognostic score for prediction of prognosis and chemosensitivity of pancreatic ductal adenocarcinoma.
    Zhang XP; Chen Q; Liu Q; Wang Y; Wang F; Zhao ZM; Zhao GD; Lau WY; Gao YZ; Liu R
    J Cell Mol Med; 2021 Jun; 25(12):5615-5627. PubMed ID: 33942483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LncRNA co-expression network analysis reveals novel biomarkers for pancreatic cancer.
    Giulietti M; Righetti A; Principato G; Piva F
    Carcinogenesis; 2018 Jul; 39(8):1016-1025. PubMed ID: 29796634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Construction and analysis of dysregulated lncRNA-associated ceRNA network identified novel lncRNA biomarkers for early diagnosis of human pancreatic cancer.
    Zhou M; Diao Z; Yue X; Chen Y; Zhao H; Cheng L; Sun J
    Oncotarget; 2016 Aug; 7(35):56383-56394. PubMed ID: 27487139
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrative analysis of gene expression profiles reveals specific signaling pathways associated with pancreatic duct adenocarcinoma.
    Li J; Tan W; Peng L; Zhang J; Huang X; Cui Q; Zheng J; Tan W; Wu C; Lin D
    Cancer Commun (Lond); 2018 Apr; 38(1):13. PubMed ID: 29764514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic relevance of molecular subtypes and master regulators in pancreatic ductal adenocarcinoma.
    Janky R; Binda MM; Allemeersch J; Van den Broeck A; Govaere O; Swinnen JV; Roskams T; Aerts S; Topal B
    BMC Cancer; 2016 Aug; 16():632. PubMed ID: 27520560
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of Prognostic Markers and Potential Therapeutic Targets using Gene Expression Profiling and Simulation Studies in Pancreatic Cancer.
    Singh S; Kaushik AC; Gupta H; Jhinjharia D; Sahi S
    Curr Comput Aided Drug Des; 2024; 20(6):955-973. PubMed ID: 37711100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of hub genes and analysis of prognostic values in pancreatic ductal adenocarcinoma by integrated bioinformatics methods.
    Lu Y; Li C; Chen H; Zhong W
    Mol Biol Rep; 2018 Dec; 45(6):1799-1807. PubMed ID: 30173393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PDAC-ANN: an artificial neural network to predict pancreatic ductal adenocarcinoma based on gene expression.
    Almeida PP; Cardoso CP; de Freitas LM
    BMC Cancer; 2020 Jan; 20(1):82. PubMed ID: 32005189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 119.